The value of pharma schemes rose as investors shifted focus to drugmakers, considered defensive in uncertain times. As per data from Value Research the mid-cap category offered the highest return of 8.93%, followed by multi-caps which returned 7.88%.
Goldman Sachs buys shares worth Rs 50 crore in this smallcap stock via block deal
Goldman Sachs acquired approximately 11 lakh shares of TD Power Systems in a block deal valued at Rs 50.30 crore, purchasing them at Rs 460